Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Marie Louise (Marieke) De Bruin"'
Autor:
Anna Birna Almarsdottir, Sofia Kälvemark Sporrong, Susanne Kaae, Louise C. Druedahl, Timo Minssen, Ramune Jacobsen, Marie Louise (Marieke) De Bruin, Susan Heydon
Publikováno v:
Research in Social and Administrative Pharmacy. 15:e41-e55
Autor:
Luisa Ibáñez, Stéphanie Tcherny-Lessenot, Belen Oliva, Christiane Gasse, Toine Egberts, Ruth Brauer, Frank De Vries, Consuelo Huerta, Helga Gardarsdottir, Marie Louise (Marieke) De Bruin, Juhaeri Juhaeri, Francisco Jose De Abajo Iglesias, Tjeerd Van Staa, Lamiae Grimaldi-Bensouda
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:156-165
Purpose: To assess the impact of a variety of methodological parameters on the association between six drug classes and five key adverse events in multiple databases. Methods: The selection of Drug-Adverse Event pairs was based on public health impac
Autor:
Luisa Ibáñez, Stéphanie Tcherny-Lessenot, Mark De Groot, Belen Oliva, Christiane Gasse, Toine Egberts, Ruth Brauer, Frank De Vries, Consuelo Huerta, Helga Gardarsdottir, Marie Louise (Marieke) De Bruin, Juhaeri Juhaeri, Francisco Jose De Abajo Iglesias, Tjeerd Van Staa, Lamiae Grimaldi-Bensouda
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:5-10
The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT) initiative was a collaborative European project that sought to address limitations of current methods in the field of pharmacoepidemiology and pharmac
Autor:
Aleman, B. M. P., Krul, I. M., Winden, A. W. J. Opstal, Janus, C. P. M., Eggermond, A. M., Marie Louise (Marieke) De Bruin, Hauptmann, M., Krol, A. D. G., Schaapveld, M., Broeks, A., Kooijman, K. R., Fase, S., Lybeert, M., Zijlstra, J. M., Maazen, R. W. M., Kesminiene, A., Diallo, I., Vathaire, F., Russell, N. S., Leeuwen, F. E.
Publikováno v:
Haematologica, 101, 63-63
ResearcherID
Cancer Research, 77
ResearcherID
Cancer Research, 77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::651cdcc131ba89842cc7bb59b3306cf5
http://hdl.handle.net/1887/115415
http://hdl.handle.net/1887/115415
Publikováno v:
Europe PubMed Central
ResearcherID
ResearcherID
The aim of this study was to determine the outcomes and timing within the product life cycle of all benefit-risk reassessment procedures for marketed products that were completed by the committee for medicinal product for human use during 2001-2012.A
Autor:
Vermeer, N. S., Duijnhoven, R. G., Straus, S. M. J. M., Blackburn, S., Hoogendoorn, W. E., Mantel-Teeuwisse, A. K., Egberts, A. C. G., Leufkens, H. G. M., Marie Louise (Marieke) De Bruin
Publikováno v:
ResearcherID
Background: Risk management plans (RMPs) form an integral part of the regulatory approval of new drugs in Europe. The RMP details all safety concerns and associated pharmacovigilance activities, facilitating postapproval knowledge increase. The proce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::93f8b933b24d5ac62600dd479200f265
https://dspace.library.uu.nl/handle/1874/330041
https://dspace.library.uu.nl/handle/1874/330041
Publikováno v:
Europe PubMed Central
This study used spontaneous reports of adverse events to estimate the risk for developing cardiac arrhythmias due to the systemic use of non-sedating antihistamine drugs and compared the risk estimate before and after the regulatory action to recall
Autor:
Marie Louise (Marieke) De Bruin, Puijenbroek, E. P., Egberts, A. C. G., Hoes, A. W., Leufkens, H. G. M.
Publikováno v:
British Journal of Clinical Pharmacology, 53(4), 370-374. Wiley
University of Copenhagen
University of Copenhagen
AIMS: This study used spontaneous reports of adverse events to estimate the risk for developing cardiac arrhythmias due to the systemic use of non-sedating antihistamine drugs and compared the risk estimate before and after the regulatory action to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::356e768e8165d96041736a49b8a8979a
https://research.rug.nl/en/publications/45fd3fdc-4158-45e9-856e-989b66027f2e
https://research.rug.nl/en/publications/45fd3fdc-4158-45e9-856e-989b66027f2e
Autor:
Druedahl, Louise C., Marie Louise (Marieke) De Bruin, Marco van de Weert, Timo Minssen, Hans Hoogland, Anna Birna Almarsdottir
Publikováno v:
University of Copenhagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::291314f7254601eded28c0b9346f73d8
https://curis.ku.dk/portal/en/publications/medicines-authority-regulators-and-industry-perspectives-on-the-european-regulation-of-biosimilars(c8580218-8fe1-4b1c-8a6f-cd9fe7e84971).html
https://curis.ku.dk/portal/en/publications/medicines-authority-regulators-and-industry-perspectives-on-the-european-regulation-of-biosimilars(c8580218-8fe1-4b1c-8a6f-cd9fe7e84971).html
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::74fe7f96100fe72f90fea2edd7241b4e
http://europepmc.org/abstract/med/19293607
http://europepmc.org/abstract/med/19293607